Table 2. Confocal scanning laser tomography (CSLT) and spectral domain optical coherence tomography (SD-OCT) based neuroretinal rim parameters including six optic nerve sectors.
Gobal | Nasal | Nasal superior | Nasal inferior | Temporal | Temporal superior | Temporal inferior | |
---|---|---|---|---|---|---|---|
Glaucoma | |||||||
BMO-MRW, μm (SD-OCT) | 124.33 (±42.53) | 135.91 (±53.03) | 139.52 (±58.56) | 158.78 (±63.58) | 110.57 (±43.98) | 97.07 (±55.68) | 119.38 (±55.07) |
RNFLT, μm (SD-OCT) (SD) | 54.10 (±15.43) | 44.52 (±18.40) | 60.86 (±23.99) | 54.95 (±23.59) | 51.02 (±18.63) | 66.11 (±24.47) | 71.09 (±35.06) |
Rim area, mm2 (CSLT) | 0.86 (±0.36) | 0.28 (±0.24) | 0.14 (±0.07) | 0.14 (±0.07) | 0.13 (±0.06) | 0.08 (±0.06) | 0.10 (±0.06) |
Ocular hypertension | |||||||
BMO-MRW, μm (SD-OCT) | 226.38 (±38.37) | 252.47 (±53.77) | 255.61 (±72.03) | 306.09 (±68.21) | 171.80 (±26.16) | 223.12 (±53.11) | 257.69 (±54.22) |
RNFLT, μm (SD-OCT) | 72.27 (±17.19) | 53.55 (±16.87) | 76.00 (±26.73) | 72.36 (±30.00) | 57.91 (±10.28) | 107.64 (±27.34) | 117.45 (±26.59) |
Rim area, mm2 (CSLT) | 1.66 (±0.39) | 0.46 (±0.15) | 0.25 (±0.08) | 0.26 (±0.06) | 0.26 (±0.09) | 0.21 (±0.05) | 0.23 (±0.07) |
Normal controls | |||||||
BMO-MRW, μm (SD-OCT) | 243.08 (±44.07) | 248.28 (±53.84) | 258.94 (±65.44) | 301.10 (±62.81) | 192.72 (±41.32) | 232.98 (±56.47) | 278.36 (±52.80) |
RNFLT, μm (SD-OCT) | 82.69 (±15.76) | 66.90 (±17.26) | 92.26 (±28.66) | 87.17 (±25.85) | 62.81 (±12.97) | 113.43 (±24.58) | 126.94 (±25.28) |
Rim area, mm2 (CSLT) | 1.54 (±0.34) | 0.46 (±0.11) | 0.22 (±0.06) | 0.24 (±0.06) | 0.23 (±0.09) | 0.18 (±0.06) | 0.20 (±0.07) |
Abbreviations: BMO-MRW, Bruch’s membrane opening minimum rim width; CSLT, confocal scanning laser tomography; ONH, optic nerve head; RNFLT, retinal nerve fiber layer thickness; SD-OCT, spectral domain optical coherence tomography.